Skip to main content
. 2019 Jul 29;12(7):100044. doi: 10.1016/j.waojou.2019.100044

Table 1.

Overview on treatment groups.

Active Immunotherapy Passive Immunotherapy Control
WT BALBc (normal IgE levels) rHER-2 4D5 PBS
ΔM1M2 (low IgE levels) rHER-2 4D5 PBS
KN1 (high IgE levels) rHER-2 4D5 PBS